Teleflex PLEUR-EV: Sterility Risk in Thoracic Catheters
Teleflex recalls sterile thoracic catheters due to lack of sterility assurance. Affected units may cause infections if used without proper sterility.
Lower-risk recall
Teleflex is recalling this product due to a lack of assurance of sterility.
Contact the company
What happened, in plain English
Teleflex is recalling sterile thoracic catheters that could be contaminated, risking infections if used. This affects medical procedures where the catheter drains fluid from the chest. Read more at govinfonow.com/recall/63276-teleflex-pleur-ev-sterility-risk-in-thoracic-catheters.
Source Summary by GovInfoNow · govinfonow.com/recall/63276-teleflex-pleur-ev-sterility-risk-in-thoracic-catheters · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1298-2021
Cite this page
“Teleflex PLEUR-EV: Sterility Risk in Thoracic Catheters.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63276-teleflex-pleur-ev-sterility-risk-in-thoracic-catheters. Based on FDA recall #Z-1298-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1298-2021%22&limit=1).
Why it’s dangerous
The catheters lack proper sterility assurance, which could lead to infections if used in medical procedures. This is a risk during drainage of fluid from the chest cavity.
Who’s affected
Healthcare providers using these catheters for medical procedures. Patients undergoing thoracic drainage treatments are most at risk.
How to tell if you have this one
Check for the catalog number DRAC-32S. Look for manufacturing lot/serial numbers starting with 73J2000276. The product is sold in single-use packaging.
- Brand
Teleflex- Product
PLEUR-EVAC Thoracic Catheters (CATHETER, IRRIGATION). The thoracic catheter is a sterile, non pyrogenic, single use- Category
Medical device
What to do — step by step
Check Product Details
Verify the catalog number DRAC-32S and lot/serial numbers starting with 73J2000276.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 7 states.
FDA distribution: “US Nationwide distribution in the states of IL, PA, FL, NJ, CT, NY, TN.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Connecticut, Florida, Illinois, New Jersey, New York, Pennsylvania, Tennessee.
Recall timeline
FDA terminated this recall 5.4 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1298-2021 (February 12, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1298-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.